Curcumin induces apoptosis in trophoblast model cell line

Tatit Nurseta, Yahya Irwanto, I W.A. Wiyasa, Rahajeng Rahajeng, Imelda Imelda, Putu A.R. Ratnawati



DOI: https://doi.org/10.13181/mji.v27i2.1821

Abstract


Background: Several studies have reported that curcumin exerts chemopreventive effects in various type of cancers, through several mechanisms, however, the effect of curcumin on carcinogenesis in patients with hydatidiform mole has not yet been investigated. This study was conducted to evaluate the effect of curcumin on apoptosis, proliferation, and nuclear translocation of endothelial nitricoxide synthase in trophoblast cells induced by estradiol in complete hydatidiform mole (CHM).

Methods: In this in vitro study, trophoblast cells were divided into six groups, the control group (trophoblast cells were exposed to 100 pg/mL of 17-β estradiol) and the treatment group (trophoblast cells were exposed to 100 pg/mL of 17-β estradiol in the presence of curcumin with doses: 50, 100, 200, 400, and 800 µM). At the end of study, the cell proliferation was analyzed using MTT assay and apoptosis with TUNEL test in each group thropoblast cell. eNOS translocation was assayed using confocal laser scanning microscopy at the various dose of curcumin.

Results: Curcumin at the doses of 200, 400, and 800 µM significantly decreased the proliferation and increased the apoptotic index in curcumin-treated group compared to those in the control group (p<0.05). All doses of curcumin treatment significantly decreased the nuclear eNOS expression compared to that in the control group. The three highest doses of curcumin increased cytoplasmic eNOS expression compared to that in control group.

Conclusion: Curcumin inhibits the proliferation and modulates the apoptosis of trophoblast cells induced by estradiol in CHM involvement.


Keywords


apoptosis, curcumin, eNOS, hydatidiform mole, trophoblast

Full Text:

PDF

References


  1. Strohl A, Lurain J. Clinical epidemiology of gestational trophoblastic disease. Curr Obstet Gynecol Rep. 2014;3:40–3. https://doi.org/10.1007/s13669-013-0070-7
  2. Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles. Biochem Biophys Res Comm. 2014;446:555–60. https://doi.org/10.1016/j.bbrc.2014.03.003
  3. Shupnik MA. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene. 2004;23(48):7979–89. https://doi.org/10.1038/sj.onc.1208076
  4. Cheskis BJ, Greger J, Cooch N, McNally C, McLarney S, Lam HS, et al. MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways. Steroids. 2008;73(9–10):901–15. https://doi.org/10.1016/j.steroids.2007.12.028
  5. Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis. 2013;34(3):503–12. https://doi.org/10.1093/carcin/bgt034
  6. Ying L, Hofseth LJ. An Emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007;67(4):1407–10. https://doi.org/10.1158/0008-5472.CAN-06-2149
  7. Xun W, Zhi FW, Yin X, Rui R, Bao LH, Ze XS. Association between three eNOS polymorphisms and cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2014;15(13):5317–24. https://doi.org/10.7314/APJCP.2014.15.13.5317
  8. Temiz C, Arslan M, Sayin M, Vatansever M, Giray G, Va A. Effects of nitric oxide-vascular endothelial growth factor systems in chick embryo cerebral vasculogenesis and angiogenesis. J Clin Anal Med. 2012;3(4):393–7.
  9. Barbieri A, Palma G, Rosati A, Giudice A, Falco A, Petrillo A, et al. Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth. J Cell Mol Med. 2012;16(4):920–6. https://doi.org/10.1111/j.1582-4934.2011.01375.x
  10. Barut A, Harma M, Arikan I, Barut F. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases. Int J Gynecol Cancer. 2010; 20(3):337–40. https://doi.org/10.1111/IGC.0b013e3181b7a35e
  11. Lu Q, Schnitzler GR, Ueda K, Iyer LK, Diomede OI, Andrade T, et al. ER alpha rapid signaling is required for estrogen induced proliferation and migration of vascular endothelial cells. PLoS ONE. 2016;11(4): e0152807. https://doi.org/10.1371/journal.pone.0152807
  12. Vanini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015;6:334–43. https://doi.org/10.1016/j.redox.2015.08.009
  13. Zhou L, Wang Y, Tian D, Yang J, Yang Z. Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma. Mol Med Rep. 2012;6(6):1261–6. https://doi.org/10.3892/mmr.2012.1096
  14. Bandyopadhyay D. Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer. Front Chem. 2014;2:113. https://doi.org/10.3389/fchem.2014.00113
  15. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:12. https://doi.org/10.1186/1476-4598-10-12
  16. Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des. 2013;19:2032–46. https://doi.org/10.2174/1381612811319110006
  17. Abuelba H, Cotrutz CE, Stoica BA, Stoica L, Olinici D, Petreus T. In vitro evaluation of curcumin effects on breat adenocarcinoma 2D and 3D cultures. Rom J Morphol Embryol. 2015; 56(1):71–6.
  18. Jamalzadeh L, Ghafoori H, Sariri R, Rabati H, Nasirzade J, Hasani H. Cytotoxic effects of some common organic solvent on MCF-7, RAW-264.7 and human umbilical vein endothelial cells. Avicenna J Med Biochem. 2015;4(1):e33453.
  19. Acharya S, Reddy R, Kuppili, Chaganti KL, Bose K. Proteases in apoptosis: protocols and methods. in: bose k, editor.proteases in apoptosis: pathways, protocols and translational. 1st ed. Switzerland; Springer International Publishing; 2015. p. 143–202.
  20. Rajesh E, Sankari LS, Malathi M, Krupaa JR. Naturally occurring products in cancer therapy. J Pharm Bioallied Sci. 2015;7(Suppl 1):S181–S3. https://doi.org/10.4103/0975-7406.155895
  21. Park W, Amin AR, Chen ZG, Shin DM. New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila). 2013;6(5):387–400. https://doi.org/10.1158/1940-6207.CAPR-12-0410
  22. Du Y, Feng J, Wang RM, Zhang H, Liu J. Effects of flavonoids from Potamogeton crispus L. on proliferation, migration, and invasion of human ovarian cancer cells. PLoS One. 2015; 10(6): e0130685. https://doi.org/10.1371/journal.pone.0130685
  23. Mahmud M, Diwoni A, Filiczak N, Janicka M, Gubernatus J. Long-circulating curcumin-loaded liposome formulations with high incorporation effeciency, stability and anticancer activity towards pancreatic adenocarcinoma cell lines in vitro. PLoS One. 2016. 10:1371. http://dx.doi.org/10.1371/journal.pone.0167787
  24. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in nuclear factor-kappaB (NF-kB) activation levels and in inhibitory of apoptosis proteins (IAP) gene expression. Cancer Letters. 2005;224(1):53–65. https://doi.org/10.1016/j.canlet.2004.10.051
  25. Nanni S, Aiello A, Re A, Guffanti A, Benvenuti V, Collusi C. Estrogen-dependent dynamic profile of eNOS-DNA assosiations in prostate cancer. PLoS One. 2013. 10:371–79. https://doi.org/10.1371/journal.pone.0062522





Copyright (c) 2018 Tatit Nurseta

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles and issues in Medical Journal of Indonesia have unique DOI number registered in Crossref.
 
Romeo
 
http://mji.ui.ac.id/journal/index.php/mji/pages/view/stat 
Unique Visitors